Antitumor Activity of Some Prenylated Xanthones

被引:32
作者
Castanheiro, Raquel A. P. [1 ]
Silva, Artur M. S. [2 ,3 ]
Campos, Nair A. N. [1 ]
Nascimento, Maria S. J. [1 ,4 ]
Pinto, Madalena M. M. [1 ,5 ]
机构
[1] Univ Porto, Ctr Quim Med, Fac Farm, CEQUIMED, Rua Anibal Cunha 164, P-4050047 Porto, Portugal
[2] Univ Aveiro, Dept Quim, P-3810193 Aveiro, Portugal
[3] Univ Aveiro, QOPNA, P-3810193 Aveiro, Portugal
[4] Univ Porto, Fac Farm, Serv Microbiol, P-4050047 Porto, Portugal
[5] Univ Porto, Fac Farm, Serv Quim Organ, P-4050047 Porto, Portugal
来源
PHARMACEUTICALS | 2009年 / 2卷 / 02期
关键词
xanthones; prenylation; dehydrogenation; antitumor activity; NMR spectroscopy;
D O I
10.3390/ph2020033
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Pyranoxanthones 6-8 were obtained by dehydrogenation of the respective dihydropyranoxanthones 3-5 with DDQ in dry dioxane. Two prenylated xanthones 10,11 were obtained from the reaction of 1-hydroxyxanthone (9) with prenyl bromide in alkaline medium, or by condensation of xanthone 9 with isoprene in the presence of orthophosphoric acid. The structural elucidation of the two new compounds 6,11, as well as an update of data for the already described prenylated derivatives 7,8,10 were accomplished by IR, UV, HRMS and NMR (H-1, C-13, HSQC and HMBC) techniques. The effect of the prenylated xanthone derivatives on the in vitro growth of human tumor cell lines MCF-7 (breast adenocarcinoma) and NCI-H460 (non-small cell lung cancer) is also reported. Compounds 10 and 11 have been found to exhibit a moderate growth inhibitory activity against the MCF-7 cell line.
引用
收藏
页码:33 / 43
页数:11
相关论文
共 18 条
[1]   ACID-CATALYZED CONDENSATION OF ISOPRENE WITH PHENOLS - FORMATION OF 2,2-DIMETHYLCHROMANS [J].
AHLUWALIA, VK ;
ARORA, KK ;
JOLLY, RS .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1982, (02) :335-338
[2]   Dihydroxyxanthones prenylated derivatives: Synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7 [J].
Castanheiro, Raquel A. P. ;
Pinto, Madalena M. M. ;
Silva, Artur M. S. ;
Cravo, Sara M. M. ;
Gales, Luis ;
Damas, Ana M. ;
Nazareth, Nair ;
Nascimento, Maria S. J. ;
Eaton, Graham .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (18) :6080-6088
[3]  
Fernandes EGR, 1998, MAGN RESON CHEM, V36, P305, DOI 10.1002/(SICI)1097-458X(199804)36:4<305::AID-OMR193>3.0.CO
[4]  
2-N
[5]   XANTHONES .4. A NEW SYNTHESIS OF HYDROXYXANTHONES AND HYDROXYBENZOPHENONES [J].
GROVER, PK ;
SHAH, GD ;
SHAH, RC .
JOURNAL OF THE CHEMICAL SOCIETY, 1955, :3982-3985
[6]  
HELBOE P, 1973, Archiv for Pharmaci og Chemi Scientific Edition, V1, P69
[7]   Synthesis of naturally occurring rubilactone, mollugin, and dihydromollugin of Rubia cordifolia [J].
Ho, LK ;
Yu, HJ ;
Ho, CT ;
Don, MJ .
JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 2001, 48 (01) :77-79
[8]   Design and synthesis of new pyranoxanthenones bearing a nitro group or an aminosubstituted side chain on the pyran ring. Evaluation of their growth inhibitory activity in breast cancer cells [J].
Kolokythas, George ;
Kostakis, Ioannis K. ;
Pouli, Nicole ;
Marakos, Panagiotis ;
Kousidou, Olga Ch. ;
Tzanakakis, George N. ;
Karamanos, Nikos K. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2007, 42 (03) :307-319
[9]  
MESQUITA AA, 1968, ANAL CHIM ACTA, V42, P311
[10]   FEASIBILITY OF A HIGH-FLUX ANTICANCER DRUG SCREEN USING A DIVERSE PANEL OF CULTURED HUMAN TUMOR-CELL LINES [J].
MONKS, A ;
SCUDIERO, D ;
SKEHAN, P ;
SHOEMAKER, R ;
PAULL, K ;
VISTICA, D ;
HOSE, C ;
LANGLEY, J ;
CRONISE, P ;
VAIGROWOLFF, A ;
GRAYGOODRICH, M ;
CAMPBELL, H ;
MAYO, J ;
BOYD, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (11) :757-766